Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019;15(10):2264-2268.
doi: 10.1080/21645515.2019.1597595. Epub 2019 Apr 23.

Challenges and perspectives on the use of mobile laboratories during outbreaks and their use for vaccine evaluation

Trina Racine  1   2 , Gary P Kobinger  1   2   3   4
Affiliations

Challenges and perspectives on the use of mobile laboratories during outbreaks and their use for vaccine evaluation

Trina Racine et al. Hum Vaccin Immunother. 2019.

Abstract

Mobile laboratories provide diagnostic capabilities for routine surveillance and patient identification during an outbreak. In either situation, they face many challenges including identification of the appropriate assay(s) to employ, logistical arrangements, and providing for the health and safety of the laboratory staff. Great strides have been made over the last decade in the development of mobile laboratories with assays that require minimal infrastructure and technical experience. This knowledge and expertise have been developed in partnership with many researchers and public health officials who live in regions prone to infectious disease outbreaks. Mobile laboratories should now also be used in the evaluation of novel vaccines and therapeutics in remote locations. Clinical mobile laboratories will include similar diagnostic capabilities as outbreak response mobile labs, but will also include additional point-of-care instruments operated under Good Clinical Practice guidelines. They will also operate rigorous data management plans so that the data collected will satisfy regulatory agencies during the licensure process. Failure to deploy an adequate clinical mobile laboratory when administering a novel biological product in a remote location is a significant limitation to any collected scientific data that could ultimately undermine clinical development and availability of life-saving interventions.

Keywords: Mobile laboratory; diagnostics; outbreak response; vaccine and therapeutic evaluation.

PubMed Disclaimer

References

    1. Inglis TJ, Garrow SC, Adams C, Henderson M, Mayo M.. Dry-season outbreak of melioidosis in Western Australia. Lancet. 1998;352:1600. doi:10.1016/S0140-6736(05)61047-1. - DOI - PubMed
    1. Wölfel R, Stoecker K, Fleischmann E, Gramsamer B, Wagner M, Molkenthin P, Di Caro A, Günther S, Ibrahim S, Genzel GH, et al. Mobile diagnostics in outbreak response, not only for Ebola: a blueprint for a modular and robust field laboratory. Euro Surveill. 2015;20(44):pii=30055. doi:10.2807/1560-7917.ES.2015.20.44.30055. - DOI - PubMed
    1. Paweska JT, van Vuren PJ, Meier GH, le Roux C, Conteh OS, Kemp A, Fourie C, Naidoo P, Naicker S, Ohaebosim P, et al. South African Ebola diagnostic response in Sierra Leone: a modular high biosafety field laboratory. PLoS Neg Trop Dis. 2017;11(6):e0005665. doi:10.1371/journal.pntd.0005665. - DOI - PMC - PubMed
    1. Zhang Y, Gong Y, Wang C, Liu W, Wang Z, Xia Z, Bu Z, Lu H, Sun Y, Zhang X, et al. Rapid deployment of a mobile biosafety level-3 laboratory in Sierra Leone during the 2014 Ebola virus epidemic. PLoS Neg Trop Dis. 2017;11(5):e0005622. doi:10.1371/journal.pntd.0005622. - DOI - PMC - PubMed
    1. Reusken C, Niedrig M, Pas S, Anda P, Baize S, Charrel R, Di Caro A, Drosten C, Fernandez-Garcia MD, Franco L, et al. Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014. J Clin Virol. 2015;62:124–34. doi:10.1016/j.jcv.2014.11.007. - DOI - PubMed

MeSH terms